amifostine anhydrous has been researched along with Neurodegenerative Diseases in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nayak, SK | 1 |
| Panesar, PS | 1 |
| Kumar, H | 1 |
1 review available for amifostine anhydrous and Neurodegenerative Diseases
| Article | Year |
|---|---|
p53-Induced apoptosis and inhibitors of p53.
Topics: Amifostine; Apoptosis; Autoimmune Diseases; Benzothiazoles; Humans; Li-Fraumeni Syndrome; Neurodegen | 2009 |